Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea
· Delayed Price · Currency is KRW
8,250.00
-30.00 (-0.36%)
At close: Dec 5, 2025
Bio Solution Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2020 | FY 2019 |
| Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 8,275 | 7,744 | 8,882 |
| Other Revenue | -0 | - | 0 |
| Revenue | 8,275 | 7,744 | 8,882 |
| Revenue Growth (YoY) | -6.84% | -12.81% | - |
| Cost of Revenue | 3,573 | 3,498 | 3,033 |
| Gross Profit | 4,702 | 4,246 | 5,850 |
| Selling, General & Admin | 3,453 | 3,541 | 3,436 |
| Research & Development | 3,208 | 3,230 | 3,645 |
| Amortization of Goodwill & Intangibles | 92.97 | 91.39 | 84.54 |
| Other Operating Expenses | 149.13 | 147.87 | 137.2 |
| Operating Expenses | 7,499 | 7,576 | 7,717 |
| Operating Income | -2,797 | -3,330 | -1,868 |
| Interest Expense | -47.28 | -40.48 | -52.6 |
| Interest & Investment Income | 1,452 | 1,427 | 859.13 |
| Currency Exchange Gain (Loss) | -3.38 | -15.13 | 4.03 |
| Other Non Operating Income (Expenses) | 42.76 | 55.51 | 12.08 |
| EBT Excluding Unusual Items | -1,353 | -1,903 | -1,045 |
| Gain (Loss) on Sale of Investments | 65.77 | 103.52 | 347.5 |
| Pretax Income | -1,283 | -1,800 | -697.54 |
| Net Income | -1,283 | -1,800 | -697.54 |
| Net Income to Common | -1,283 | -1,800 | -697.54 |
| Shares Outstanding (Basic) | 24 | 24 | 24 |
| Shares Outstanding (Diluted) | 24 | 24 | 24 |
| Shares Change (YoY) | 1.40% | 1.29% | - |
| EPS (Basic) | -53.63 | -75.33 | -29.57 |
| EPS (Diluted) | -53.69 | -75.33 | -29.67 |
| Free Cash Flow | -1,660 | -3,077 | -4,785 |
| Free Cash Flow Per Share | -69.41 | -128.79 | -202.87 |
| Gross Margin | 56.82% | 54.83% | 65.86% |
| Operating Margin | -33.80% | -43.00% | -21.03% |
| Profit Margin | -15.50% | -23.24% | -7.85% |
| Free Cash Flow Margin | -20.06% | -39.73% | -53.87% |
| EBITDA | -964.75 | -1,529 | -331.19 |
| EBITDA Margin | -11.66% | -19.75% | -3.73% |
| D&A For EBITDA | 1,833 | 1,800 | 1,536 |
| EBIT | -2,797 | -3,330 | -1,868 |
| EBIT Margin | -33.80% | -43.00% | -21.03% |
| Advertising Expenses | - | 119.42 | 89.35 |
Source: S&P Capital IQ. Standard template.
Financial Sources.